UPDATE: Needham & Company Downgrades Akebia Therapeutics (AKBA) to Hold Mar 31, 2022 07:17AM
Needham & Company Reiterates Akebia Therapeutics (AKBA) at Buy, Results From INNO2VATE Trial Support Approval of vadadustat Mar 2, 2022 12:53PM
Akebia Therapeutics (AKBA) Reiterated at Buy by Needham & Company, New Vifor Partnership is a Vote of Confidence Ahead of FDA Decision Feb 22, 2022 03:50PM
Akebia Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference Apr 12, 2021 08:00AM
Akebia Therapeutics (AKBA) PT Raised to $18 at Needham & Company May 5, 2020 01:56PM


Mar 24, 2020 07:37AM Companies with NDRs 3/24
Nov 21, 2019 06:49AM Companies with NDRs 11/21
Apr 5, 2019 04:19PM Akebia Therapeutics to Present at the 18th Annual Needham Healthcare Conference
Aug 9, 2018 01:40PM Akebia Therapeutics (AKBA) PT Lowered to $18 at Needham & Company
Mar 21, 2018 08:30AM Akebia Therapeutics to Present at Upcoming Investor Conferences
Jul 6, 2017 07:00AM Akebia Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters
Jun 29, 2017 05:37AM Akebia Therapeutics (AKBA) Prices 4M Share Offering at $14.50/Sh
Jun 28, 2017 10:46PM Akebia Announces Pricing of Public Offering of Common Stock
May 16, 2017 11:19AM Akebia Therapeutics (AKBA) PT Raised to $21 at Needham & Company
Apr 26, 2017 03:04PM Akebia Therapeutics (AKBA) PT Raised to $18 at Needham & Company
Mar 29, 2017 04:05PM Akebia to Present at the 16th Annual Needham Healthcare Conference
Dec 20, 2016 02:15PM Otsuka Partnership Removes Akebia Therapeutics (AKBA) Financial Overhang - Needham & Company
Apr 5, 2016 07:00AM Akebia to Present at the 15th Annual Needham Healthcare Conference
Jan 6, 2016 10:43PM Akebia Therapeutics (AKBA) Prices 7.25M Shares at $9
Jan 6, 2016 09:26PM Akebia Prices Public Offering of Common Stock
Jan 4, 2016 04:10PM Akebia Therapeutics (AKBA) Announces $75M Common Stock Offering
Jan 4, 2016 04:10PM Akebia Therapeutics Announces Proposed Public Offering of Common Stock
Dec 14, 2015 10:45AM Akebia (AKBA) PT Raised to $18 at Needham & Company
Oct 6, 2015 01:43PM Needham & Company Reiterates Buy on Akebia Therapeutics (AKBA) Following Successful Meetings with FDA and EMA
May 11, 2015 06:16AM Needham & Company Starts Akebia Therapeutics (AKBA) at Buy
Apr 22, 2015 04:01PM Akebia Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 17, 2015 06:10AM Akebia Therapeutics (AKBA) Prices 7.27M Common Offering at $8.25/Share
Apr 16, 2015 09:07PM Akebia Therapeutics Prices Public Offering of Common Stock
Apr 14, 2015 04:23PM Akebia Therapeutics (AKBA) Announces $60M Common Offering
Apr 14, 2015 04:22PM Akebia Therapeutics Announces Proposed Public Offering of Common Stock